UBS Group’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-221
| Closed | -$6.39K | – | 10931 |
|
|
2025
Q4 | $6.39K | Sell |
221
-8,388
| -97% | -$159K | ﹤0.01% | 8557 |
|
|
2025
Q3 | $66.8K | Sell |
8,609
-22,411
| -72% | -$168K | ﹤0.01% | 7369 |
|
|
2025
Q2 | $230K | Buy |
31,020
+18,228
| +142% | +$160K | ﹤0.01% | 6633 |
|
|
2025
Q1 | $110K | Buy |
12,792
+6,301
| +97% | +$97.2K | ﹤0.01% | 6978 |
|
|
2024
Q4 | $232K | Sell |
6,491
-12,450
| -66% | -$644K | ﹤0.01% | 6362 |
|
|
2024
Q3 | $895K | Buy |
18,941
+17,542
| +1,254% | +$774K | ﹤0.01% | 4752 |
|
|
2024
Q2 | $70.3K | Sell |
1,399
-10,188
| -88% | -$737K | ﹤0.01% | 6425 |
|
|
2024
Q1 | $1.3M | Buy |
11,587
+5,456
| +89% | +$542K | ﹤0.01% | 4372 |
|
|
2023
Q4 | $356K | Buy |
6,131
+3,853
| +169% | +$155K | ﹤0.01% | 5370 |
|
|
2023
Q3 | $72.3K | Sell |
2,278
-4,667
| -67% | -$222K | ﹤0.01% | 6059 |
|
|
2023
Q2 | $571K | Sell |
6,945
-471
| -6% | -$68.9K | ﹤0.01% | 4710 |
|
|
2023
Q1 | $762K | Sell |
7,416
-4,128
| -36% | -$579K | ﹤0.01% | 4349 |
|
|
2022
Q4 | $1.69M | Buy |
11,544
+10,492
| +997% | +$1.77M | ﹤0.01% | 3558 |
|
|
2022
Q3 | $178K | Buy |
1,052
+699
| +198% | +$114K | ﹤0.01% | 5199 |
|
|
2022
Q2 | $41K | Sell |
353
-252
| -42% | -$23.7K | ﹤0.01% | 6073 |
|
|
2022
Q1 | $60K | Sell |
605
-6,642
| -92% | -$776K | ﹤0.01% | 6313 |
|
|
2021
Q4 | $1.13M | Buy |
7,247
+3,718
| +105% | +$723K | ﹤0.01% | 4278 |
|
|
2021
Q3 | $832K | Buy |
3,529
+2,592
| +277% | +$757K | ﹤0.01% | 4344 |
|
|
2021
Q2 | $318K | Sell |
937
-2,546
| -73% | -$964K | ﹤0.01% | 5044 |
|
|
2021
Q1 | $1.41M | Buy |
3,483
+3,229
| +1,271% | +$1.57M | ﹤0.01% | 3902 |
|
|
2020
Q4 | $169K | Buy |
254
+136
| +115% | +$75.6K | ﹤0.01% | 5344 |
|
|
2020
Q3 | $55K | Buy |
118
+11
| +10% | +$5.56K | ﹤0.01% | 5581 |
|
|
2020
Q2 | $62K | Sell |
107
-897
| -89% | -$306K | ﹤0.01% | 5689 |
|
|
2020
Q1 | $146K | Sell |
1,004
-815
| -45% | -$142K | ﹤0.01% | 4968 |
|
|
2019
Q4 | $261K | Buy |
1,819
+679
| +60% | +$49.6K | ﹤0.01% | 5405 |
|
|
2019
Q3 | $45K | Buy |
1,140
+840
| +280% | +$61.1K | ﹤0.01% | 6259 |
|
|
2019
Q2 | $30K | Buy |
300
+240
| +400% | +$28.3K | ﹤0.01% | 6334 |
|
|
2019
Q1 | $8K | Sell |
60
-232
| -79% | -$29.2K | ﹤0.01% | 6943 |
|
|
2018
Q4 | $30K | Buy |
292
+159
| +120% | +$25.2K | ﹤0.01% | 6488 |
|
|
2018
Q3 | $33K | Buy |
133
+59
| +80% | +$19.8K | ﹤0.01% | 6468 |
|
|
2018
Q2 | $33K | Buy |
74
+9
| +14% | +$3.95K | ﹤0.01% | 6315 |
|
|
2018
Q1 | $26K | Buy |
65
+14
| +27% | +$5.53K | ﹤0.01% | 6214 |
|
|
2017
Q4 | $21K | Sell |
51
-13
| -20% | -$5.67K | ﹤0.01% | 6515 |
|
|
2017
Q3 | $28K | Sell |
64
-3
| -4% | -$1.18K | ﹤0.01% | 6211 |
|
|
2017
Q2 | $24K | Buy |
+67
| New | +$23.2K | ﹤0.01% | 6166 |
|